Abstract
Background The pathophysiological mechanisms that may differentially impact brain health and cognitive aging outcomes among Latino compared with non-Latino White (NLW) adults in the U.S remain incompletely understood. Recent evidence suggests that neurofilament light (NfL) levels, a biomarker of neuronal injury predictive of dementia risk, is associated with cardiovascular risk factors in both Latino and NLW populations. The current study examines whether associations between plasma NfL levels and markers for cardiovascular health differ among U.S. Mexican American (MA) and NLW adults enrolled in the Health and Aging Brain Study: Health Disparities (HABS-HD). Methods Data from 1317 participants (648 MA and 669 NLW) were analyzed, including phenotypic, neuroimaging, and plasma NfL data. Cardiovascular health factors included total volume of white matter hyperintensities (WMH), and diagnoses of hypertension, diabetes, and CVD. Results We found that NfL burden levels among MA and NLW participants differed as a function of diabetes and CVD diagnosis, with steeper differences observed in the MA group. Additionally, the association between WMH volume and NfL varied between the two groups, with a steeper association observed in the MA group. Conclusions These findings highlight the potential utility of NfL as a prognostic biomarker for CVD and neurodegeneration, particularly among MA adults. Further research is needed to clarify the mechanisms underlying these associations and to develop targeted neurodegenerative prevention strategies that address disparities in brain aging.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MMD is supported by the NIH NIMH (K23MH131466), Alzheimer's Association (AARGD-22-924896).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the North Texas Regional Institutional Review Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos